Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder—Reply

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2022-07, Vol.328 (2), p.214-215
Main Authors: Preskorn, Sheldon H, Risinger, Robert, Kakar, Rishi
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a221t-3d8742ba876bceb1cc1da0311d01684d6c0bf12b5b2a24c43d67ce015e16e4a33
cites cdi_FETCH-LOGICAL-a221t-3d8742ba876bceb1cc1da0311d01684d6c0bf12b5b2a24c43d67ce015e16e4a33
container_end_page 215
container_issue 2
container_start_page 214
container_title JAMA : the journal of the American Medical Association
container_volume 328
creator Preskorn, Sheldon H
Risinger, Robert
Kakar, Rishi
description
doi_str_mv 10.1001/jama.2022.8349
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2688568829</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2794060</ama_id><sourcerecordid>2688568829</sourcerecordid><originalsourceid>FETCH-LOGICAL-a221t-3d8742ba876bceb1cc1da0311d01684d6c0bf12b5b2a24c43d67ce015e16e4a33</originalsourceid><addsrcrecordid>eNo1kE1LxDAQhoMouK5ePXjK0Utrvtqmx3XXL1hQ_MBjSZPZNUvb1CYV9-aP8Bf6S2xZHRgGhuedgQehU0piSgi92KhaxYwwFksu8j00oQmXEU9yuY8mhOQyyoQUh-jI-w0ZivJsgsqnvqxss-5VhRfwWYOB4GprbAP4w-OHSmkoHVaNwTPdB8CztQ0qWNfgmfdOWxXA4Fcb3vClbV2lOryw3nUGup-v70doq-0xOlipysPJ35yil-ur5_lttLy_uZvPlpFijIaIG5kJViqZpeXwk2pNjSKcUkNoKoVJNSlXlJVJyRQTWnCTZhoITYCmIBTnU3S-u9t27r0HH4raeg1VpRpwvS9YKmUyNMsHNN6hunPed7Aq2s7WqtsWlBSjzGKUWYwyi1HmEDjbBcb1P8uyXJCU8F-opXJ9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2688568829</pqid></control><display><type>article</type><title>Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder—Reply</title><source>JAMA Network</source><creator>Preskorn, Sheldon H ; Risinger, Robert ; Kakar, Rishi</creator><creatorcontrib>Preskorn, Sheldon H ; Risinger, Robert ; Kakar, Rishi</creatorcontrib><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2022.8349</identifier><language>eng</language><publisher>American Medical Association</publisher><ispartof>JAMA : the journal of the American Medical Association, 2022-07, Vol.328 (2), p.214-215</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a221t-3d8742ba876bceb1cc1da0311d01684d6c0bf12b5b2a24c43d67ce015e16e4a33</citedby><cites>FETCH-LOGICAL-a221t-3d8742ba876bceb1cc1da0311d01684d6c0bf12b5b2a24c43d67ce015e16e4a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Preskorn, Sheldon H</creatorcontrib><creatorcontrib>Risinger, Robert</creatorcontrib><creatorcontrib>Kakar, Rishi</creatorcontrib><title>Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder—Reply</title><title>JAMA : the journal of the American Medical Association</title><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo1kE1LxDAQhoMouK5ePXjK0Utrvtqmx3XXL1hQ_MBjSZPZNUvb1CYV9-aP8Bf6S2xZHRgGhuedgQehU0piSgi92KhaxYwwFksu8j00oQmXEU9yuY8mhOQyyoQUh-jI-w0ZivJsgsqnvqxss-5VhRfwWYOB4GprbAP4w-OHSmkoHVaNwTPdB8CztQ0qWNfgmfdOWxXA4Fcb3vClbV2lOryw3nUGup-v70doq-0xOlipysPJ35yil-ur5_lttLy_uZvPlpFijIaIG5kJViqZpeXwk2pNjSKcUkNoKoVJNSlXlJVJyRQTWnCTZhoITYCmIBTnU3S-u9t27r0HH4raeg1VpRpwvS9YKmUyNMsHNN6hunPed7Aq2s7WqtsWlBSjzGKUWYwyi1HmEDjbBcb1P8uyXJCU8F-opXJ9</recordid><startdate>20220712</startdate><enddate>20220712</enddate><creator>Preskorn, Sheldon H</creator><creator>Risinger, Robert</creator><creator>Kakar, Rishi</creator><general>American Medical Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220712</creationdate><title>Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder—Reply</title><author>Preskorn, Sheldon H ; Risinger, Robert ; Kakar, Rishi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a221t-3d8742ba876bceb1cc1da0311d01684d6c0bf12b5b2a24c43d67ce015e16e4a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Preskorn, Sheldon H</creatorcontrib><creatorcontrib>Risinger, Robert</creatorcontrib><creatorcontrib>Kakar, Rishi</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Preskorn, Sheldon H</au><au>Risinger, Robert</au><au>Kakar, Rishi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder—Reply</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><date>2022-07-12</date><risdate>2022</risdate><volume>328</volume><issue>2</issue><spage>214</spage><epage>215</epage><pages>214-215</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><pub>American Medical Association</pub><doi>10.1001/jama.2022.8349</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2022-07, Vol.328 (2), p.214-215
issn 0098-7484
1538-3598
language eng
recordid cdi_proquest_miscellaneous_2688568829
source JAMA Network
title Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder—Reply
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T20%3A23%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sublingual%20Dexmedetomidine%20vs%20Placebo%20and%20Acute%20Agitation%20Associated%20With%20Bipolar%20Disorder%E2%80%94Reply&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Preskorn,%20Sheldon%20H&rft.date=2022-07-12&rft.volume=328&rft.issue=2&rft.spage=214&rft.epage=215&rft.pages=214-215&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2022.8349&rft_dat=%3Cproquest_cross%3E2688568829%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a221t-3d8742ba876bceb1cc1da0311d01684d6c0bf12b5b2a24c43d67ce015e16e4a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2688568829&rft_id=info:pmid/&rfr_iscdi=true